[ad_1]
World Corona 19 vaccine comparison table.
The government has concluded a vaccine contract with AstraZeneca, a vaccine developer for Corona 19.
A health official said on day 3: “We recently signed a vaccine supply contract with AstraZeneca. When negotiations with individual vaccine developers conclude soon, we plan to announce the current status of the contract and the amount to be insured.” The AstraZeneca vaccine requires two doses and, as a result of the initial data analysis of the phase 3 clinical trial, the prophylactic effect of the vaccine was 70-90% depending on the method of administration.
The company previously promised a supply price of $ 3 to $ 5 (about 3,000 to 5,500 won) per dose (for one dose). The government has negotiated purchase contracts for 5 corona vaccine products19 that entered phase 3 clinical trials. AstraZeneca, known to have signed a contract for the first time, is reported to have been negotiating with Pfizer, Johnson & Johnson, Modena and NovaVax, who approved emergency use in the UK on Day 2.
Pfizer and Moderna have stated that the vaccines they are developing have preventive effects of 95% and 94.1%, respectively. The price is $ 19.5 per dose for Pfizer (about 21,500 won) and $ 15-25 for Modena (about 16,500-27,000 won). Two doses of the Pfizer and Modena vaccine are also required. AstraZeneca vaccine is somewhat inferior in its preventive effect, but has the advantage that it can be delivered at 2-8 degrees compared to Pfizer, which must be delivered through a ‘cold chain’ at a cryogenic temperature below -70 ℃. Additionally, you have the advantage that domestic manufacturing is possible by signing a vaccine shipment production contract with SK Bioscience in July.
Initially, the government plans to insure 10 million people through the ‘Covax Facility’, an international project for the joint purchase and distribution of vaccines, and to buy an additional 20 million people through individual negotiations with global pharmaceutical companies. Health and Welfare Minister Park Neung-hoo recently said: “We are looking for considerably more contracts than 30 million people, which is 60% of the total population.” In next year’s budget, 900 billion won has been allocated to purchase vaccines to increase the number of vaccination targets to 44 million.
Reporter Kim Doo-yong [email protected]
[ad_2]
